Lonza profits rise

Lonza, the Swiss fine chemicals company, has reported a 5.2 per
cent rise in net profits for the first half of the year to SFr161
million (€109m) after good performances from all its main operating
divisions.

Lonza, the Swiss fine chemicals company, has reported a 5.2 per cent rise in net profits for the first half of the year to SFr161 million (€109m) after good performances from all its main operating divisions.

Group sales increased by 2.2 per cent to SFr1.3 billion, but operating income of SFr217 million was below last year's result of SFr223 million due to the sale of the company's energy business in December 2001, which had provided SFr18 million in the first half of 2001. On a comparative basis, group operating income increased by 5.9 per cent from SFr205 million to SFr217 million.

Lonza is a leading producer of active chemical ingredients, intermediates and biotechnology solutions to the pharmaceutical and agrochemical industries, and offers a broad catalogue of organic intermediates for a wide range of applications such as pharmaceuticals, agrochemicals, vitamins, food and foodstuff, dyes and pigments, adhesives and fragrances.

The company's biotechnology activities showed the expected healthy growth in sales and operating income, while the exclusive synthesis business faced a competitive environment, with increased pressure on plant loading and margins. The organic fine and performance chemicals businesses achieved an increase in profitability based on continual improvement of the operating performance of the plants and a decrease in some raw material costs. The polymer intermediates business recovered further due to the positive effect of the realignment of market players in Europe and stable demand in most industrial applications, Lonza said in a statement.

Lonza also confirmed that it would not be selling its polymer intermediates business as had previously been the case, as it now felt that the division would offer better value to shareholders by remaining part of the group.

Related topics Suppliers Antioxidants/carotenoids

Related news

Show more

Related products

show more

Curcumin on Autonomic Balance: The First In Its Class

Curcumin on Autonomic Balance: The First In Its Class

Content provided by Theravalues Corporation | 17-Sep-2024 | Research Study

Theracurmin Super® is a Japan-made curcumin powder that is the first to patent Amorphous Conversion Technology in a proprietary formulation to enhance...

Fast acting Specialty Lutein Esters

Fast acting Specialty Lutein Esters

Content provided by Ennature Biopharma, a Division of India Glycols Limited | 16-Sep-2024 | Case Study

Xanthogreen® is a clinically validated, clean label ingredient from marigold flowers that helps boost your eye health with visible effects in as little...

13X Boost in Glutathione with LipoAvail™

13X Boost in Glutathione with LipoAvail™

Content provided by Effepharm Ltd | 03-Sep-2024 | Product Brochure

Glutathione is a powerful antioxidant and vital metabolic regulator within cells. But it is unstable, susceptible to light, humidity, heat, gastric acid,...

Related suppliers

Follow us

Products

View more

Webinars